{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:04:52Z","timestamp":1761581092594},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T00:00:00Z","timestamp":1369699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0065348","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T04:00:44Z","timestamp":1369800044000},"page":"e65348","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Na\u00efve Patients with Advanced HIV-1 Infection in the HAART Era"],"prefix":"10.1371","volume":"8","author":[{"given":"Daisuke","family":"Mizushima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihisa","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","article-title":"Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment","volume":"114","author":"DA Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199112053252303","article-title":"Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation","volume":"325","author":"JM Goodrich","year":"1991","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"AC Kalil","year":"2005","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e5512","DOI":"10.1371\/journal.pone.0005512","article-title":"Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy","volume":"4","author":"AC Kalil","year":"2009","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/lt.20562","article-title":"Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients","volume":"12","author":"JM Park","year":"2006","journal-title":"Liver Transpl"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/j.1600-6143.2005.00866.x","article-title":"A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients","volume":"5","author":"A Humar","year":"2005","journal-title":"Am J Transplant"},{"key":"ref7","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"JE Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00002030-199707000-00007","article-title":"Cost-effectiveness of cytomegalovirus (CMV) disease prevention in patients with AIDS: oral ganciclovir and CMV polymerase chain reaction testing","volume":"11","author":"DN Rose","year":"1997","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJM199606063342302","article-title":"Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group","volume":"334","author":"SA Spector","year":"1996","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00002030-199803000-00004","article-title":"A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"12","author":"CL Brosgart","year":"1998","journal-title":"AIDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1310\/hct1003-143","article-title":"Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030","volume":"10","author":"DA Wohl","year":"2009","journal-title":"HIV Clin Trials"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI1101","article-title":"Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients","volume":"101","author":"SA Spector","year":"1998","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1128\/JVI.73.8.7027-7030.1999","article-title":"Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS","volume":"73","author":"SA Spector","year":"1999","journal-title":"J Virol"},{"key":"ref14","article-title":"Efficiency and Risk Factors for CMV Transmission in Seronegative Hematopoietic Stem Cell Recipients","author":"SA Pergam","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.transproceed.2011.12.025","article-title":"Post-renal transplant cytomegalovirus infection: study of risk factors","volume":"44","author":"VB Kute","year":"2012","journal-title":"Transplant Proc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e25571","DOI":"10.1371\/journal.pone.0025571","article-title":"Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa","volume":"6","author":"K Fielding","year":"2011","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/QAI.0b013e3181a254c2","article-title":"Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007)","volume":"51","author":"R Micol","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/323782","article-title":"Diagnosis and monitoring of human cytomegalovirus diseases in patients with human immunodeficiency virus infection by use of a real-time PCR assay","volume":"33","author":"A Yoshida","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/375843","article-title":"Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360)","volume":"37","author":"A Erice","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0008-4182(05)80086-9","article-title":"Iatrogenic risk factors for cytomegalovirus retinitis","volume":"40","author":"WG Hodge","year":"2005","journal-title":"Can J Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(04)16500-8","article-title":"Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy","volume":"363","author":"JR Deayton","year":"2004","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0161-6420(03)00089-7","article-title":"The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy","volume":"110","author":"JH Kempen","year":"2003","journal-title":"Ophthalmology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAD.0b013e3283324283","article-title":"The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals","volume":"24","author":"M Ray","year":"2010","journal-title":"AIDS"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","article-title":"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies","volume":"373","author":"JA Sterne","year":"2009","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"KK Biron","year":"2006","journal-title":"Antiviral Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0065348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T07:26:16Z","timestamp":1595834776000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0065348"}},"subtitle":[],"editor":[{"given":"Michael","family":"Nevels","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,28]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0065348","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,28]]}}}